Xuejuan Yu

Dr. Xuejuan Yu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
WZWei Zhou
Wei Zhou
XYXuejuan Yu
Xuejuan Yu
SSShuang Sun
Shuang Sun
XZXuehai Zhang
Xuehai Zhang
WYWenjing Yang
Wenjing Yang
ZJZheng Jiang
Zheng Jiang
The main characteristic of glioma is recurrence, even after intensive multidisciplinary treatment. Studies show that enhanced invasive ability will increase the ability of tumor cells to escape from the primary tumor mass, which is a key factor contributing to tumor relapse and recurrence. In this study, we assessed the expression of MMP-2, MMP-9, two important matrix metallopeptidases that increase the invasive ability of glioma, and their suppressors, TIMP-1, TIMP-2 in glioma tissues from primary and recurrent glioma patients by immunohistochemistry. Glioma cells and nude mice were used for in vitro and in vivo studies. Results showed that the expression of MMP-2 and MMP-9 in recurrent gliomas were significantly higher than those in primary gliomas (P = 3.075 × 10-11, P = 1.510 × 10-5, respectively). We also found that radiotherapy increased the expression of MMP-9, but had no effect on MMP-2 and TIMP-1/2. With glioma cell line U251, we found that irradiation increased the expression of MMP-9 in vitro. Tumor tissues from an orthotopic xenograft model showed that after irradiation treatment, the expression of MMP-9 increased significantly in vivo. We also found that knocking down MMP-9 decreased irradiation-induced invasion obviously. Above all, we concluded that higher expressions of MMP-2/-9 indicate poor prognosis in glioma recurrence. The increased expression of MMP-9 after radiotherapy suggests that MMP-9 might be an important target in the radiosensitization of glioma.

30 May 2014 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
SLShangang Liu
Shangang Liu
CLChengli Li
Chengli Li
XYXuejuan Yu
Xuejuan Yu
MLMing Liu
Ming Liu
TFTingyong Fan
Tingyong Fan
RRRuimei Ren
Ruimei Ren

6 August 2021 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
CLChunhai Li
Chunhai Li
DWDexiang Wang
Dexiang Wang
FYFengxia Yang
Fengxia Yang
YSYang Song
Yang Song
XYXuejuan Yu
Xuejuan Yu
WZWei Zhou
Wei Zhou
Background: We aim to analyze the risk factors for pneumothorax associated with computed tomography (CT)-guided percutaneous core needle biopsy (PCNB) of the lung. Whether the lung function characteristics are related to pneumothorax is unclear. Methods: We retrospectively evaluated 343 patients who received CT-guided pulmonary PCNBs and underwent preoperative pulmonary function testing. Demographical, lesion-related, procedure-related features and histopathological diagnosis, as well as results of pulmonary function test were analyzed as risk factors of pneumothorax Results: Variables associated with higher rate of pneumothorax were location of lesion, presence of emphysema, and dwell time. The proportion of middle lobe, lingular, or lower lobe lesions in pneumothorax group (30/50, 60.0%) is higher than non-pneumothorax group (113/293, 38.6%). The incidence of emphysema in pneumothorax group was significantly higher than that in non-pneumothorax group (34.0% vs. 7.5%). Obstructive pulmonary function abnormalities, not restrictive, mixed ventilation function abnormalities and small airway dysfunction, correlated with pneumothorax. Multivariate logistic regression analysis showed lower location of lesion sampled and presence of emphysema were independent predictors of pneumothorax. Although dwell time, FEV1/FVC ratio, FEF50%, FEF75% and FEF25–75% were significantly correlated with pneumothorax on univariate analysis, these were not confirmed to be independent predictors. Conclusions: Patients with obstructive pulmonary dysfunction have a higher risk of pneumothorax. Presence of emphysema was the most important predictor of pneumothorax, followed by location of lesion.

1 August 2014
Verified
Journal Article
Closed access
XYXuejuan Yu
Xuejuan Yu
SLShangang Liu
Shangang Liu
ZCZhaoqiu Chen
Zhaoqiu Chen
PZPinliang Zhang
Pinliang Zhang
JZJianbo Zhang
Jianbo Zhang
RRRuimei Ren
Ruimei Ren

1 October 2014
Verified
Journal Article
Closed access
XYXuejuan Yu
Xuejuan Yu
RRRuimei Ren
Ruimei Ren
SLShangang Liu
Shangang Liu
JYJinming Yu
Jinming Yu